| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |